Impact of esophageal temperature monitoring guided atrial fibrillation ablation on preventing asymptomatic excessive transmural injury

Por Kunihiko Kiuchi, MD, FHRS, Katsunori Okajima, MD, Akira Shimane, MD, Gaku Kanda, MD, Kiminobu Yokoi, MD, Jin Teranishi, MD, Kousuke Aoki, MD, Misato Chimura, MD, Takayoshi Toba, MD, Shogo Oishi, MD, Takahiro Sawada, MD, Yasue Tsukishiro, MD, Tetsuari Onishi, MD, Seiichi Kobayashi, MD, Yasuyo Taniguchi, MD, Shinichiro Yamada, MD, Yoshinori Yasaka, MD, Hiroya Kawai, MD, Akihiro Yoshida, MD, Koji Fukuzawa, MD, Mitsuaki Itoh, MD, Kimitake Imamura, MD, Ryudo Fujiwara, MD, Atsushi Suzuki, MD, Tomoyuki Nakanishi, MD, Soichiro Yamashita, MD, Ken-ichi Hirata, MD, Hiroshi Tada, MD, FHRS, Hiro Yamasaki, MD, Yoshihisa Naruse, MD, Miyako Igarashi, MD, Kazutaka Aonuma, MD
Publicado em 2016-02-01